Listen "How Vedanta Biosciences prepared for Series D Funding"
Episode Synopsis
Daniel Couto is the COO of Vedanta Biosciences, a leading microbiome company who recently completed $68 Million Series D Financing. Dan has nearly 30 years of experience starting and advancing biopharmaceutical development and manufacturing organizations to higher levels of capability, growth and productivity.Vedanta is developing a novel class of therapies that modulate pathways of interaction between the human microbiome and the host immune system.
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.